One in five people have a genetic heart risk that their doctor has probably never tested for. A drug trial to address it is expected to report results soon.

Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

U.S. Races to Set Up Quarantine Facility in Kenya for Americans Exposed to Ebola

The move represents a departure from the procedure used during previous outbreaks of the virus.

‘It’s Like a Pandemic.’ Cuba’s Tourism Industry Is Completely Unraveling.

Fuel shortages and economic turmoil are scaring away foreign visitors.

Europe Is Starting to Think Putin Will Expand the War Beyond Ukraine

While fears that Russia could expand the conflict to Europe aren’t new, recent developments have made…

North Korea Tests Its Own Version of U.S. Himars Missiles

The move is part of Kim Jong Un’s effort to modernize North Korea’s conventional forces.

Israel Kills New Hamas Military Chief 11 Days After Strike on Predecessor

The strike came despite a U.S.-brokered cease-fire and is part of a campaign of killing militants…

CVC Sells Naturgy Stake for $3.57 Billion

The move from CVC comes after a BlackRock-owned fund in March sold its entire stake in…

AkzoNobel Shares Jump After $14.5 Billion Nippon Paint, Sherwin-Williams Bid

Akzo rejected the takeover proposal and said its boards continued to recommend a merger with U.S.…

Lululemon Settles Dispute With Founder

The company will add two directors chosen by Chip Wilson, who has agreed to stop criticizing…

Universal Music Shareholder Deals Blow to Bill Ackman’s $65 Billion Bid

The chief executive of Bollore Group called on the record label to reject the bid from…